Cargando…
Metformin-Induced Eosinophilic Interstitial Lung Disease
Metformin, a mainstay treatment for type two diabetes mellitus has several side effects, ranging from mild to life-threatening ones. One report has found the combination of metformin/glibenclamide a culprit for interstitial lung disease. Other studies have shown that metformin has a protective effec...
Autores principales: | Alyami, Sami M, Alrasheed, Sarah K, Albogami, Bashayer A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228833/ https://www.ncbi.nlm.nih.gov/pubmed/37261145 http://dx.doi.org/10.7759/cureus.38339 |
Ejemplares similares
-
Recent Advances in the Treatment of Interstitial Lung Diseases
por: Bang, Aneesh A, et al.
Publicado: (2023) -
Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020) -
Daptomycin-Induced Acute Eosinophilic Pneumonia
por: Portalatin, Gilda M, et al.
Publicado: (2021) -
Daptomycin-induced Acute Eosinophilic Pneumonia
por: Kumar, Sundeep, et al.
Publicado: (2018) -
Eosinophilic Ascites: An Infrequent Presentation of Eosinophilic Gastroenteritis
por: Sequeira, Mafalda, et al.
Publicado: (2022)